Khiron Life Sciences
(OTC) KHRNF
Khiron Life Sciences Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$16.14M
Net Income (TTM)
-CA$30.66M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
667.96 (High)
Dividend
$0.00
Beta (Volatility)
667.96 (High)
Price
$0.00
Volume
1,000
Open
$0.00
Price
$0.00
Volume
1,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Jun 2, 2026
Dividend
$0.00
Beta (Volatility)
667.96 (High)
Price
$0.00
Volume
1,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Jun 2, 2026
KHRNF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Khiron Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
310
CEO
Álvaro F. Torres, MBA
Website
www.khiron.caHeadquarters
Vancouver, BC V6C 2B5, CA
KHRNF Financials
Key Financial Metrics (TTM)
Gross Margin
22.47%
Operating Margin
-174.52%
Net Income Margin
-258.92%
Return on Equity
-68.62%
Return on Capital
-55.65%
Return on Assets
-78.37%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
0
Volume
1.00K
Avg. Volume
4.30K
Financials (TTM)
Gross Profit
CA$6.67M
Operating Income
-CA$14.55M
EBITDA
-CA$12.97M
Operating Cash Flow
-CA$15.01M
Capital Expenditure
-CA$2.78M
Free Cash Flow
-CA$17.80M
Cash & ST Invst.
CA$1.94M
Total Debt
CA$2.56M
Khiron Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
CA$3.39M
-3.8%
Gross Profit
CA$1.65M
-8.8%
Gross Margin
48.83%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
310
N/A
Net Income
-CA$3.58M
-7.2%
EBITDA
-CA$2.89M
+32.3%
Quarterly Fundamentals
Total Cash
CA$1.94M
-87.4%
Total Debt
CA$2.56M
+32.6%
Accounts Receivable
CA$4.38M
+7.3%
Inventory
CA$9.81M
-1.3%
Long Term Debt
CA$1.34M
N/A
Short Term Debt
CA$1.23M
+290.3%
Return on Assets
-78.37%
N/A
Return on Invested Capital
-64.62%
N/A
Free Cash Flow
-CA$5.92M
-16.8%
Operating Cash Flow
-CA$5.04M
-3.9%